Brief Description
Developer of drug discovery platform designed to selectively activate and expand the innate immune system against cancer. The company specializes in providing a specific type of T cell for the immune system to fight solid tumors by increasing the response rate of a bispecific antibody drug, enabling patients to survive a deadly disease like cancer.
Inventors
Daniel Portnoy, Thomas Patrick Burke, Juliana Durack, Jonathan Lewis Portman, Christopher Rae, Rafael Jose Rivera Lugo, Kimberly Makiko Sogi, Sarah Ann Stanley, Erik Skidmore Van Dis
Company Founders
Jonathan Kotula (Ph.D.), Russell Carrington (UC Berkeley, Ph.D. ’05, Mechanical Engineering), Daniel Portnoy
Timeline
- 2022. Company founded